These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33121133)

  • 41. The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia.
    Hefter H; Ürer B; Brauns R; Rosenthal D; Meuth SG; Lee JI; Albrecht P; Samadzadeh S
    J Neurol; 2022 Nov; 269(11):5991-6002. PubMed ID: 35842881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence on botulinum toxin in selected disorders.
    Zakin E; Simpson D
    Toxicon; 2018 Jun; 147():134-140. PubMed ID: 29408357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.
    Rekand T; Biering-Sörensen B; He J; Vilholm OJ; Christensen PB; Ulfarsson T; Belusa R; Ström T; Myrenfors P; Maisonobe P; Dalager T
    BMJ Open; 2019 May; 9(5):e024340. PubMed ID: 31061021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Xeomin in the treatment of cervical dystonia.
    Benecke R
    Eur J Neurol; 2009 Dec; 16 Suppl 2():6-10. PubMed ID: 20002740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in sensorimotor network activation after botulinum toxin type A injections in patients with cervical dystonia: a functional MRI study.
    Nevrlý M; Hluštík P; Hok P; Otruba P; Tüdös Z; Kaňovský P
    Exp Brain Res; 2018 Oct; 236(10):2627-2637. PubMed ID: 29971454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.
    Dressler D; Paus S; Seitzinger A; Gebhardt B; Kupsch A
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):1014-9. PubMed ID: 23687362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life in long-term botulinum toxin treatment of cervical dystonia: Results of a cross sectional study.
    Moll M; Rosenthal D; Hefter H
    Parkinsonism Relat Disord; 2018 Dec; 57():63-67. PubMed ID: 30150129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
    Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ
    J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia.
    Costanzo M; Belvisi D; Berardelli I; Maraone A; Baione V; Ferrazzano G; Cutrona C; Leodori G; Pasquini M; Conte A; Fabbrini G; Defazio G; Berardelli A
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
    Bleyenheuft C; Cockx S; Caty G; Stoquart G; Lejeune T; Detrembleur C
    Gait Posture; 2009 Aug; 30(2):168-72. PubMed ID: 19442523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
    Oshima M; Deitiker P; Jankovic J; Atassi MZ
    Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.
    Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1995 Dec; 59(6):601-7. PubMed ID: 7500097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia.
    Silbergleit AK; Isabell K; Turnbull J; Patel N; Boettcher E; Konnai R; Collins D; Sidiropoulos C; Schultz L
    Dysphagia; 2023 Oct; 38(5):1421-1429. PubMed ID: 37071189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.
    Ferreira JJ; Colosimo C; Bhidayasiri R; Marti MJ; Maisonobe P; Om S
    Parkinsonism Relat Disord; 2015 Feb; 21(2):111-5. PubMed ID: 25499753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy.
    Walter U; Mühlenhoff C; Benecke R; Dressler D; Mix E; Alt J; Wittstock M; Dudesek A; Storch A; Kamm C
    Neurology; 2020 May; 94(20):e2109-e2120. PubMed ID: 32332130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuation of long-term care for cervical dystonia at an academic movement disorders clinic.
    Gill CE; Manus ND; Pelster MW; Cook JA; Title W; Molinari AL; Charles D
    Toxins (Basel); 2013 Apr; 5(4):776-83. PubMed ID: 23612751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxin.
    Wöber C; Schnider P; Steinhoff N; Trattnig S; Zebenholzer K; Auff E
    Eur Neurol; 1999; 41(4):194-200. PubMed ID: 10343149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.